Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 18, 2009

AbD Serotec and BBInternational Ink Reciprocal Marketing Agreement

  • AbD Serotec , the research and diagnostics antibody division of MorphoSys , and BBInternational  signed an agreement to comarket each other’s products and services worldwide.

    The agreement will give BBI’s customers access to over 13,000 antibodies and immunological reagents and custom monoclonal antibodies developed from the MorphoSys HuCAL library, along with AbD Serotec’s large- and small-scale antibody production and conjugation services.

    AbD Serotec will in turn have direct access to BBI’s complementary range of services for the production of gold-labeled reagents, contract research and development, and manufacture of rapid diagnostic tests for point of care markets.



Related content

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »